Compounds > vx 497
Page last updated: 2024-09-04

vx 497 and olaparib

vx 497 has been researched along with olaparib in 1 studies

Compound Research Comparison

Studies
(vx 497)		Trials
(vx 497)		Recent Studies (post-2010)
(vx 497)		Studies
(olaparib)		Trials
(olaparib)		Recent Studies (post-2010) (olaparib)
25371,3131721,258

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)olaparib (IC50)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)1.538
Cytochrome P450 1A2Homo sapiens (human)0.02
CholinesteraseHomo sapiens (human)0.0035
Poly [ADP-ribose] polymerase 1Homo sapiens (human)0.1741
Cytochrome P450 2D6Homo sapiens (human)0.02
Protein mono-ADP-ribosyltransferase PARP6Homo sapiens (human)1.8
Protein mono-ADP-ribosyltransferase PARP15Homo sapiens (human)7.6216
Protein mono-ADP-ribosyltransferase PARP10Homo sapiens (human)5.2854
Protein mono-ADP-ribosyltransferase PARP16Homo sapiens (human)5.1143
Poly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)2.3349
Histamine H3 receptorCavia porcellus (domestic guinea pig)0.001
Poly [ADP-ribose] polymerase 2Homo sapiens (human)0.1866
Protein mono-ADP-ribosyltransferase PARP4Homo sapiens (human)0.4087
Protein mono-ADP-ribosyltransferase PARP3Homo sapiens (human)0.1315

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and olaparib

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023